Aggregation-induced bioprobe for plasma membrane-specific imaging and photodynamic cancer cell ablation

Spectrochim Acta A Mol Biomol Spectrosc. 2023 May 15:293:122486. doi: 10.1016/j.saa.2023.122486. Epub 2023 Feb 11.

Abstract

Selective labelling of the plasma membrane (PM) by fluorescence imaging techniques enables an intuitive analysis of cell status together with dynamic changes, and therefore is of great value. We herein disclose a novel carbazole-based probe, CPPPy, that shows aggregation-induced emission (AIE) property and is observed to selectively accumulate at the PM of living cells. Benefiting from its good biocompatibility and PM-targeted specificity, CPPPy can light up the PM of cells by high-resolution imaging even at a low concentration of 200 nM. Simultaneously, CPPPy is capable of generating both singlet oxygen and free radical-dominated species upon visible light irradiation, which further induces irreversible growth inhibition and necrocytosis of tumor cells. This study thus provides new insight into the construction of multifunctional fluorescence probes with PM-specific bioimaging and photodynamic therapy.

Keywords: Aggregation-induced emission; Bioimaging; Photodynamic therapy; Plasma membrane-specific.

MeSH terms

  • Cell Membrane
  • Light
  • Neoplasms* / drug therapy
  • Optical Imaging
  • Photochemotherapy* / methods
  • Photosensitizing Agents / pharmacology
  • Singlet Oxygen

Substances

  • Singlet Oxygen
  • Photosensitizing Agents